Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) - Ridker, P M; Thuren, T; Zalewski, A (Am Heart J, 2011)
et al.